The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in Scotland during the period 1983-99

被引:24
作者
Kyaw, MH
Christie, P
Jones, IG
Campbell, H
机构
[1] Scottish Ctr Infect & Environm Hlth, Glasgow G3 7LN, Lanark, Scotland
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1080/00365540110080403
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We reviewed population-based laboratory reports of invasive meningococcal. pneumococcal. Haemophilus influenzae, Group B Streptococcus (GBS) and Listeria monocytogenes isolates in order to examine the changing epidemiology of meningitis and invasive non-meningitic disease (INMD) caused by these 5 pathogens in the 2 periods before (1983-91) and after (1992-99) routine use of H. influenzae type B conjugate vaccine (Hib) in Scotland. Neissieria meningitidis was the most common cause of meningitis, accounting for 39.2%, of cases of meningitis in 1983-91 and 47/4 of cases in 1992-99, followed by H. influenzae (31%), Streptococcus pneumoniae (22.4%), GBS (3.9%) and L. monocytogenes (3.5%) in 1983-91 and S. pneumoniae (36.3%), H. influenzae (7.8%), GBS (6.1%) and L. monocytogenes (2.8%) in 1992-99. The important epidemiological features of meningitis and INMD caused by these 5 pathogens between 1983-91 and 1992-99 include: 1. The incidence of bacterial meningitis due to S. pneumoniae and GBS was stable; 2. S. pneumoniae was the predominant cause of INMD in both periods: 3. The incidences of INMD caused by N. meningitidis, GBS and S. pneumoniae increased, by 27%, 55% and 56%, respectively; 4 Decreases in the incidences of bacterial meningitis (by 50%) and INMD (by 50%) due to L. monocytogenes were detected; and 5. There were dramatic reductions in the proportions of bacterial meningitis (by 92%) and INMD (by 56%) due to H. influenzae in vaccinated and non-vaccinated individuals. Continued surveillance is necessary to monitor the disease trend, population at risk, serotype distribution and antimicrobial susceptibility in order to implement appropriate public health interventions against invasive bacterial disease.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 51 条
[1]   Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib [J].
Baker, CJ ;
Paoletti, LC ;
Wessels, MR ;
Guttormsen, HK ;
Rench, MA ;
Hickman, ME ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :142-150
[2]   OUTCOMES OF BACTERIAL-MENINGITIS IN CHILDREN - A METAANALYSIS [J].
BARAFF, LJ ;
LEE, SI ;
SCHRIGER, DL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (05) :389-394
[3]   Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis in Sweden [J].
Berg, S ;
Trollfors, B ;
Claesson, BA ;
Alestig, K ;
Gothefors, L ;
Hugosson, S ;
Lindquist, L ;
Olcen, P ;
Romanus, V ;
Strangert, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (03) :247-252
[4]   Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease [J].
Bisgard, KM ;
Kao, A ;
Leake, J ;
Strebel, PM ;
Perkins, BA ;
Wharton, M .
EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :229-237
[5]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[6]   Invasive group B streptococcal disease: The emergence of serotype V [J].
Blumberg, HM ;
Stephens, DS ;
Modansky, M ;
Erwin, M ;
Elliot, J ;
Facklam, RR ;
Schuchat, A ;
Baughman, W ;
Farley, MM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :365-373
[7]   Epidemiology of pneumococcal infections in the elderly [J].
Butler, JC ;
Schuchat, A .
DRUGS & AGING, 1999, 15 (Suppl 1) :11-19
[8]  
CAMPAGNE G, 2000, B WORLD HEALTH ORGAN, V77, P499
[9]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P473
[10]  
Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P993